For citations:
Zhuravleva M.V., Chulanov V.P., Gagarina Yu.V., Shabalina E.A. Pharmacoeconomic analysis of tixagevimab and cilgavimab combination for COVID-19 therapy. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2023;16(2):149-161. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2023.191

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.